- NEWS AND VIEWS
Bacterial peptides presented on tumour cells could be immunotherapy targets
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 592, 28-29 (2021)
doi: https://doi.org/10.1038/d41586-021-00640-9
References
Nejman, D. et al. Science 368, 973–980 (2020).
Xavier, J. B. et al. Trends Cancer 6, 192–204 (2020).
Geller, L. T. et al. Science 357, 1156–1160 (2017).
Kalaora, S. et al. Nature 592, 138–143 (2021).
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P. & Boon, T. Nature Rev. Cancer 14, 135–146 (2014).
Schumacher, T. N. & Schreiber, R. D. Science 348, 69–74 (2015).
van der Bruggen, P. et al. Science 254, 1643–1647 (1991).
Bassani-Sternberg, M. et al. Nature Commun. 7, 13404 (2016).
Waldman, A. D., Fritz, J. M. & Lenardo, M. J. Nature Rev. Immunol. 20, 651–668 (2020).